PR Newswire PLAINSBORO, N.J., Aug. 30, 2024 PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure with mildly reduced ejection fraction or heart ...
PR Newswire MISSION, Kan., Aug. 28, 2024 Understanding the risks of uncontrolled LDL cholesterol MISSION, Kan., Aug. 28, 2024 /PRNewswire/ -- (Family Features) Millions of Americans are at risk for life-threatening cardiovascular events ...
PR Newswire VANCOUVER, BC, Aug. 28, 2024 VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of ...
PR Newswire CAMBRIDGE, Mass., Aug. 28, 2024 Collaboration leverages Quotient's platform to identify somatic mutations in genes that modify the progression of cardiovascular and renal diseases Quotient and Pioneering Medicines, Flagship's ...
PR Newswire BRONX, N.Y., Aug. 23, 2024 Risk Predication Tool, Developed by Anesthesiologists at Montefiore Health System and Albert Einstein College Medicine, May Reduce Adverse Outcomes BRONX, N.Y., Aug. 23, 2024 /PRNewswire/ -- A new ...
PR Newswire ST. LOUIS, Aug. 22, 2024 Scientists conclude that classifying soymilk as "ultra-processed" may mislead consumers about its nutritional qualities. ST. LOUIS, Aug. 22, 2024 /PRNewswire/ -- The consumption of soymilk can ...
PR Newswire PONTE VEDRA, Fla., Aug. 22, 2024 PONTE VEDRA, Fla., Aug. 22, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, next-generation Vitamin K Antagonist ...
PR Newswire NEW YORK, Aug. 20, 2024 NEW YORK, Aug. 20, 2024 /PRNewswire/ -- Platelets are circulating cell fragments known to clump up and form blood clots that stop bleeding in injured vessels. Cardiologists have long known that platelets ...
PR Newswire WASHINGTON, Aug. 20, 2024 WASHINGTON, Aug. 20, 2024 /PRNewswire/ -- The Heart Failure Society of America (HFSA) has launched a new online repository called HFStats.org, for statistical heart failure data, in the form of graphics, ...
PR Newswire PONTE VEDRA, Fla., Aug. 20, 2024 PONTE VEDRA, Fla., Aug. 20, 2024 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage, next-generation VKA oral and ...
Discover how BMAL1–HIF2A interactions control circadian rhythms in heart injury, revealing a potential pathway for time-based cardioprotective therapies.
Medically tailored meals significantly improve heart failure patients’ nutrition and reduce hospital readmissions.
Early ezetimibe initiation after myocardial infarction significantly lowers cardiovascular events compared to delayed or no combination lipid-lowering therapy.
A novel diffusion model generates synthetic atrial fibrosis images to augment data for deep learning, improving prediction of AF ablation outcomes in silico.
Living in low-walkability neighborhoods is linked to a higher risk of cardiovascular disease, new research shows.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers